The BPDCN International Registry, an IMMONC initiative was recently mentioned in the UICC Members Corner.
This registry is a collaborative effort to gather comprehensive data on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare and aggressive blood cancer.
The Immune Oncology Research Institute is a member of UICC (Union for International Cancer Control), a global organization that unites the cancer community to reduce the global cancer burden, promote equitable access to cancer care, and advocate for evidence-based policies and programs. UICC works with its members, including cancer organizations, institutions, and individuals, to drive collaboration, knowledge sharing, and action in the fight against cancer.
Click here to read about the BPDCN International Registry in the UICC Members Corner Page.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.